BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37819454)

  • 1. Evaluation of new alternative methods for the identification of estrogenic, androgenic and steroidogenic effects: a comparative in vitro/in silico study.
    Najjar A; Wilm A; Meinhardt J; Mueller N; Boettcher M; Ebmeyer J; Schepky A; Lange D
    Arch Toxicol; 2024 Jan; 98(1):251-266. PubMed ID: 37819454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of estrogen and androgen activity of food contact materials by different in vitro bioassays (YES, YAS, ERα and AR CALUX) and chromatographic analysis (GC-MS, HPLC-MS).
    Mertl J; Kirchnawy C; Osorio V; Grininger A; Richter A; Bergmair J; Pyerin M; Washüttl M; Tacker M
    PLoS One; 2014; 9(7):e100952. PubMed ID: 25000404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coupling the H295R with ERα and AR U2OS CALUX assays enables simultaneous testing for estrogenic, anti-androgenic and steroidogenic modalities.
    Nikopaschou MS; Félix A; Mollergues J; Scholz G; Schilter B; Marin-Kuan M; Fussell KC
    Toxicol Sci; 2023 Jul; 194(2):191-208. PubMed ID: 37261848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol.
    Klopčič I; Markovič T; Mlinarič-Raščan I; Sollner Dolenc M
    Toxicol Lett; 2018 Sep; 294():95-104. PubMed ID: 29777833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities.
    Sonneveld E; Riteco JA; Jansen HJ; Pieterse B; Brouwer A; Schoonen WG; van der Burg B
    Toxicol Sci; 2006 Jan; 89(1):173-87. PubMed ID: 16221957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integral assessment of estrogenic potentials in sediment-associated samples: Part 2: Study of estrogen and anti-estrogen receptor-binding potentials of sediment-associated chemicals under different salinity conditions using the salinity-adapted enzyme-linked receptor assay.
    Kase R; Hansen PD; Fischer B; Manz W; Heininger P; Reifferscheid G
    Environ Sci Pollut Res Int; 2009 Jan; 16(1):54-64. PubMed ID: 19011916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, validation and integration of in silico models to identify androgen active chemicals.
    Manganelli S; Roncaglioni A; Mansouri K; Judson RS; Benfenati E; Manganaro A; Ruiz P
    Chemosphere; 2019 Apr; 220():204-215. PubMed ID: 30584954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Mono-(2-Ethylhexyl) Phthalate (MEHP) on Human Estrogen Receptor (hER) and Androgen Receptor (hAR) by YES/YAS In Vitro Assay.
    Kim DH; Park CG; Kim SH; Kim YJ
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31010227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals.
    Rotroff DM; Dix DJ; Houck KA; Knudsen TB; Martin MT; McLaurin KW; Reif DM; Crofton KM; Singh AV; Xia M; Huang R; Judson RS
    Environ Health Perspect; 2013 Jan; 121(1):7-14. PubMed ID: 23052129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional changes in steroidogenesis by perfluoroalkyl acids (PFOA and PFOS) regulate the synthesis of sex hormones in H295R cells.
    Kang JS; Choi JS; Park JW
    Chemosphere; 2016 Jul; 155():436-443. PubMed ID: 27139122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integral assessment of estrogenic potentials of sediment-associated samples. Part 1: The influence of salinity on the in vitro tests ELRA, E-Screen and YES.
    Kase R; Hansen PD; Fischer B; Manz W; Heininger P; Reifferscheid G
    Environ Sci Pollut Res Int; 2008 Jan; 15(1):75-83. PubMed ID: 18306891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review.
    Bonefeld-Jørgensen EC; Long M; Hofmeister MV; Vinggaard AM
    Environ Health Perspect; 2007 Dec; 115 Suppl 1(Suppl 1):69-76. PubMed ID: 18174953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In house validation of recombinant yeast estrogen and androgen receptor agonist and antagonist screening assays.
    Kolle SN; Kamp HG; Huener HA; Knickel J; Verlohner A; Woitkowiak C; Landsiedel R; van Ravenzwaay B
    Toxicol In Vitro; 2010 Oct; 24(7):2030-40. PubMed ID: 20732407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogenic and androgenic activities of TBBA and TBMEPH, metabolites of novel brominated flame retardants, and selected bisphenols, using the XenoScreen XL YES/YAS assay.
    Fic A; Žegura B; Gramec D; Mašič LP
    Chemosphere; 2014 Oct; 112():362-9. PubMed ID: 25048928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key learnings from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 in vitro assays.
    LeBaron MJ; Coady KK; O'Connor JC; Nabb DL; Markell LK; Snajdr S; Sue Marty M
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):23-42. PubMed ID: 24515815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Currently used pesticides and their mixtures affect the function of sex hormone receptors and aromatase enzyme activity.
    Kjeldsen LS; Ghisari M; Bonefeld-Jørgensen EC
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):453-64. PubMed ID: 23871939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of OASIS QSAR Models Using ToxCast™ in Vitro Estrogen and Androgen Receptor Binding Data and Application in an Integrated Endocrine Screening Approach.
    Bhhatarai B; Wilson DM; Price PS; Marty S; Parks AK; Carney E
    Environ Health Perspect; 2016 Sep; 124(9):1453-61. PubMed ID: 27152837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine Learning Consensus To Predict the Binding to the Androgen Receptor within the CoMPARA Project.
    Grisoni F; Consonni V; Ballabio D
    J Chem Inf Model; 2019 May; 59(5):1839-1848. PubMed ID: 30668916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characterization of the effectiveness of enhanced sewage treatment processes to eliminate endocrine activity of hospital effluents.
    Maletz S; Floehr T; Beier S; Klümper C; Brouwer A; Behnisch P; Higley E; Giesy JP; Hecker M; Gebhardt W; Linnemann V; Pinnekamp J; Hollert H
    Water Res; 2013 Mar; 47(4):1545-57. PubMed ID: 23305681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of chemical effects on aromatase activity using the H295R cell line.
    Higley EB; Newsted JL; Zhang X; Giesy JP; Hecker M
    Environ Sci Pollut Res Int; 2010 Jun; 17(5):1137-48. PubMed ID: 20087668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.